Search

Your search keyword '"Bouchard, Céline"' showing total 104 results
Start Over Author "Bouchard, Céline" Search Limiters Full Text
104 results on '"Bouchard, Céline"'

1. Effects of E4/DRSP on self-reported physical and emotional premenstrual and menstrual symptoms: data from the phase 3 clinical trial in Europe and Russia

Author

Bitzer, Johannes, Bouchard, Céline, Zatik, János, Weyers, Steven, Piltonen, Terhi, Suturina, Larisa, Apolikhina, Inna, Gemzell-Danielsson, Kristina, Jost, Maud, Creinin, Mitchell D, and Foidart, Jean-Michel

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Clinical Research, Behavioral and Social Science, Clinical Trials and Supportive Activities, Chronic Pain, Pain Research, Humans, Female, Adult, Russia, Young Adult, Premenstrual Syndrome, Europe, Androstenes, Self Report, Middle Aged, Adolescent, Drug Combinations, Surveys and Questionnaires, Dysmenorrhea, Estetrol, E4, E4/drsp, combined oral hormone contraception, menstrual distress questionnaire, Paediatrics and Reproductive Medicine, Obstetrics & Reproductive Medicine, Reproductive medicine
Abstract

PurposeTo describe the effects of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg on physical and emotional premenstrual and menstrual symptoms.Materials and methodsWe used Menstrual Distress Questionnaire (MDQ) data from a phase-3 trial (NCT02817828) in Europe and Russia with participants (18 - 50 years) using E4/DRSP for up to 13 cycles. We assessed mean changes in MDQ-t-scores from baseline to end of treatment in premenstrual (4 days before most recent flow) and menstrual (most recent flow) scores for 4 MDQ domains in starters and switchers (use of hormonal contraception in prior 3 months) and performed a shift analysis on individual symptoms within each domain.ResultsOf 1,553 treated participants, 1,398(90.0%), including 531(38%) starters, completed both MDQs. Starters reported improvements for premenstrual Pain (-1.4), Water Retention (-3.3) and Negative Affect (-2.5); and for menstrual Pain (-3.5), Water Retention (-3.4), and Negative Affect (-2.7) (all p 40% of participants for Cramps, Backache and Fatigue (domain Pain), Painful or Tender Breast and Swelling (domain Water Retention) and Mood Swings and Irritability (domain Negative Affect).ConclusionE4/DRSP starters experienced significant improvements in the domains Pain, Water Retention and Negative Affect particularly benefiting those with more severe baseline symptoms. Switchers showed minimal changes.

Published
2024

2. Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials

Author

Jensen, Jeffrey T, Kaunitz, Andrew M, Achilles, Sharon L, Zatik, János, Weyers, Steven, Piltonen, Terhi, Suturina, Larisa, Apolikhina, Inna, Bouchard, Céline, Chen, Melissa J, Apter, Dan, Jost, Maud, Foidart, Jean-Michel, and Creinin, Mitchell D

Subjects
Reproductive Medicine, Biomedical and Clinical Sciences, Clinical Trials and Supportive Activities, Pediatric, Clinical Research, Prevention, Contraception/Reproduction, Good Health and Well Being, Humans, Pregnancy, Female, United States, Adolescent, Young Adult, Adult, Estetrol, Androstenes, Contraceptives, Oral, Combined, Contraception, Estrogens, Combined oral contraception, Contraceptive efficacy, Drospirenone, E4, Native estrogen, Pearl Index, Clinical Sciences, Paediatrics and Reproductive Medicine, Public Health and Health Services, Obstetrics & Reproductive Medicine, Clinical sciences, Reproductive medicine, Health services and systems
Abstract

ObjectiveTo evaluate overall and subgroup efficacy of an estetrol (E4) 15 mg drospirenone (DRSP) 3 mg oral contraceptive in a 24/4-day regimen.Study designWe pooled efficacy outcomes from 2 pivotal phase 3 contraceptive trials with E4/DRSP conducted in the United States/Canada and Europe/Russia. We assessed Pearl Index (PI; pregnancies per 100 participant-years) and 13-cycle life-table pregnancy rates in at-risk cycles (confirmed intercourse and no other contraceptive use) among participants 16 to 35 years. We calculated PI by age and further subcategorization (contraceptive history and body mass index [BMI]). We performed multivariable analysis using Cox regression to assess impact of potential confounding factors.ResultsAnalyses included 3027 participants, of whom 451 (14.9%) had a BMI ≥30 kg/m2. The pooled PI was 1.52 (95% confidence interval 1.04-2.16) and the 13-cycle life-table pregnancy rate was 1.28% (0.83%-1.73%). We calculated unadjusted pooled PI in participants 16 to 25 years and 26 to 35 years of 1.61 (0.94-2.57) and 1.43 (0.78-2.40), respectively; in new starters and switchers of 1.88 (1.09-3.00) and 1.24 (0.68-2.08), respectively; and by BMI

Published
2022

3. Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results

Author

Creinin, Mitchell D, Westhoff, Carolyn L, Bouchard, Céline, Chen, Melissa J, Jensen, Jeffrey T, Kaunitz, Andrew M, Achilles, Sharon L, Foidart, Jean-Michel, and Archer, David F

Subjects
Hematology, Clinical Research, Clinical Trials and Supportive Activities, Patient Safety, Prevention, Contraception/Reproduction, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Reproductive health and childbirth, Androstenes, Contraceptives, Oral, Combined, Estetrol, Estrogens, Ethinyl Estradiol, Female, Humans, North America, Pregnancy, Drospirenone, Oral contraceptive, Pearl index, Clinical Sciences, Paediatrics and Reproductive Medicine, Public Health and Health Services, Obstetrics & Reproductive Medicine
Abstract

ObjectiveTo assess efficacy, cycle control, and safety of an oral contraceptive containing estetrol (E4) 15 mg and drospirenone (DRSP) 3 mg.Study designWomen aged 16 to 50 years with a body mass index ≤35 kg/m2 enrolled in this multicenter, open-label, 13-cycle, phase 3 trial evaluating E4/DRSP in a 24-active/4-placebo regimen. Follow-up was scheduled at Cycles 2, 4, 7, and 10 and within 3 weeks of completing Cycle 13. Participants used daily diaries to record pill use and vaginal bleeding. We evaluated efficacy outcomes in women 16 to 35 years and bleeding patterns and safety (adverse events [AEs]) in all participants. We assessed overall and method-failure pregnancy rates using the Pearl index (PI) and life-table analysis. Scheduled bleeding included spotting or bleeding starting during the 4-day placebo period or first 3 days of the next cycle.ResultsWe enrolled 1864 women of whom 1674 were 16 to 35 years. Women 16 to 35 years had a PI of 2.65 (95% CI 1.73-3.88), method-failure PI of 1.43 (95% CI 0.7-2.39) and 13-cycle life-table pregnancy rate of 2.1%. Scheduled bleeding occurred in 82.9% to 87.0% of women per cycle; median duration was 4.5 days. Unscheduled bleeding decreased from 30.3% in Cycle 1 to 21.3% to 22.1% during Cycles 2 to 4 and remained stable (15.5% to 19.2%) thereafter. The most frequently reported AEs were headache (5.0%) and metrorrhagia (4.6%). One-hundred thirty-two (7.1%) women discontinued the study early for an AE, most commonly for metrorrhagia (0.9%) and menorrhagia (0.8%). No thromboembolic events occurred.ConclusionE4/DRSP is an effective oral contraceptive with a predictable bleeding pattern for most women and low AE rates.Implications statementA new oral contraceptive with a novel estrogen, estetrol, combined with drospirenone has efficacy and safety within the range of other available oral contraceptives. Large phase 4 studies will be needed to confirm if this combination is associated with an improved adverse event profile or lower thrombosis risk.

Published
2021

4. International Anal Neoplasia Society Guidelines for the Practice of Digital Anal Rectal Examination.

Author

Hillman, Richard John, Berry-Lawhorn, J Michael, Ong, Jason J, Cuming, Tamzin, Nathan, Mayura, Goldstone, Stephen, Richel, Olivier, Barrosso, Luis F, Darragh, Teresa M, Law, Carmella, Bouchard, Céline, Stier, Elizabeth A, Palefsky, Joel M, Jay, Naomi, and International Anal Neoplasia Society

Subjects
International Anal Neoplasia Society, Humans, Anus Neoplasms, Diagnostic Tests, Routine, Early Diagnosis, Image Processing, Computer-Assisted, Quality Assurance, Health Care, Practice Guidelines as Topic, Optical Imaging, Obstetrics & Reproductive Medicine, Clinical Sciences
Abstract

OBJECTIVE:The aim of the study was to develop recommended techniques and quality assurance metrics for the practice of Digital Anal Rectal Examination (DARE). MATERIALS AND METHODS:The International Anal Neoplasia Society undertook a literature review and, using the AGREE II technique, developed guidelines for performing DARE. RESULTS:A consensus was formed regarding the optimum conditions and characteristics of DARE. Several Quality Assurance metrics were developed. CONCLUSIONS:Digital Anal Rectal Examination is a cheap and potentially universally available technique, which has the potential to facilitate the early diagnosis of anal cancers, when they are most amenable to treatment. These guidelines provide a basis for teaching the technique and may be used as for evaluation research.

Published
2019

5. 2016 IANS International Guidelines for Practice Standards in the Detection of Anal Cancer Precursors

Author

Hillman, Richard John, Cuming, Tamzin, Darragh, Teresa, Nathan, Mayura, Berry-Lawthorn, Michael, Goldstone, Stephen, Law, Carmella, Palefsky, Joel, Barroso, Luis F, Stier, Elizabeth A, Bouchard, Céline, Almada, Justine, and Jay, Naomi

Subjects
Cancer, Clinical Research, Prevention, Management of diseases and conditions, 7.3 Management and decision making, Anus Neoplasms, Humans, Precancerous Conditions, anal cancer, precursors, high-grade squamous intraepithelial lesions, anal intraepithelial neoplasia, high-resolution anoscopy, anal cytology, quality assurance, practice standards, diagnostics, Clinical Sciences, Obstetrics & Reproductive Medicine
Abstract

ObjectivesTo define minimum standards for provision of services and clinical practice in the investigation of anal cancer precursors.MethodsAfter initial face to face meetings of experts at the International Papillomavirus meeting in Lisbon, September 17 to 21, 2015, a first version was drafted and sent to key stakeholders. A complete draft was reviewed by the Board of the International Anal Neoplasia Society (IANS) and uploaded to the IANS Web site for all members to provide comments. The final draft was ratified by the IANS Board on June 22, 2016.ResultsThe essential components of a satisfactory high-resolution anoscopy (HRA) were defined. Minimum standards of service provision, basic competencies for clinicians, and standardized descriptors were established. Quality assurance metrics proposed for practitioners included a minimum of 50 HRAs per year and identifying 20 cases or more of anal high-grade squamous intraepithelial lesions (HSILs). Technically unsatisfactory anal cytological samples at first attempt in high-risk populations should occur in less than 5% of cases. Where cytological HSIL has been found, histological HSIL should be identified in ≥ 90% of cases. Duration of HRA should be less than 15 minutes in greater than 90% of cases. Problematic pain or bleeding should be systematically collected and reported by 10% or lesser of patients.ConclusionsThese guidelines propose initial minimum competencies for the clinical practice of HRA, against which professionals can judge themselves and providers can evaluate the effectiveness of training. Once standards have been agreed upon and validated, it may be possible to develop certification methods for individual practitioners and accreditation of sites.

Published
2016

9. Female Genital Cosmetic Surgery

Author

Leyland, Nicholas, Wolfman, Wendy, Allaire, Catherine, Awadalla, Alaa, Best, Carolyn, Dunn, Sheila, Heywood, Mark, Lemyre, Madeleine, Marcoux, Violaine, Menard, Chantal, Potestio, Frank, Rittenberg, David, Singh, Sukhbir, Shapiro, Jodi, Akhtar, Saima, Camire, Bruno, Christilaw, Jan, Corey, Julie, Nelson, Erin, Pierce, Marianne, Robertson, Deborah, Simmonds, Anne, Shaw, Dorothy, Lefebvre, Guylaine, Bouchard, Celine, Blake, Jennifer, Allen, Lisa, and Cassell, Krista

Published
2013
Full Text
View/download PDF

17. Relevance of omental pericellular adipose tissue collagen in the pathophysiology of human abdominal obesity and related cardiometabolic risk

Author

Laforest, Sofia, Tordjman, Joan, Pelletier, Mélissa, Michaud, Andréanne, Liu, Yuejun, Tchernof, André, Noël, Suzanne, Le Naour, Gilles, Bouchard, Céline, Clément, Karine, Laforest, Sofia, Tordjman, Joan, Pelletier, Mélissa, Michaud, Andréanne, Liu, Yuejun, Tchernof, André, Noël, Suzanne, Le Naour, Gilles, Bouchard, Céline, and Clément, Karine

Abstract

Background: Adipose tissue fibrosis is a relatively new notion and its relationship with visceral obesity and cardiometabolic alterations remains unclear, particularly in moderate obesity. Objective: Our objective was to examine if total and pericellular collagen accumulation are relevant for the pathophysiology of visceral obesity and related cardiometabolic risk. Subjects and methods: Surgical omental (OM) and subcutaneous (SC) fat samples were obtained in 56 women (age: 47.2±5.8 years; body mass index (BMI): 27.1±4.4 kg/m2). Body composition and fat distribution were measured by dual-energy X-ray absorptiometry and computed tomography, respectively. Total and pericellular collagen were measured using picrosirius red staining. CD68+ cells (total macrophages) and CD163+ cells (M2-macrophages) were identified using immunohistochemistry. Results: We found that only pericellular collagen percentage, especially in OM fat, was associated with higher BMI, body fat mass and adipose tissue areas as well as lower radiologic attenuation of visceral adipose tissue and altered cardiometabolic risk variables. Strong correlations between peri-adipocyte collagen percentage and total or M2-macrophage percentages were observed in both depots. Total collagen percentage in either compartment was not related to adiposity, fat distribution or cardiometabolic risk. Conclusions: As opposed to whole tissue-based assessments of adipose tissue fibrosis, collagen deposition around the adipocyte, especially in the OM fat compartment is related to total and regional adiposity as well as altered cardiometabolic risk profile.

Published
2020

22. Chirurgie esthétique génitale chez la femme

Author

Leyland, Nicholas, Wolfman, Wendy, Allaire, Catherine, Awadalla, Alaa, Best, Carolyn, Dunn, Sheila, Heywood, Mark, Lemyre, Madeleine, Marcoux, Violaine, Menard, Chantal, Potestio, Frank, Rittenberg, David, Singh, Sukhbir, Shapiro, Jodi, Akhtar, Saima, Camire, Bruno, Christilaw, Jan, Corey, Julie, Nelson, Erin, Pierce, Marianne, Robertson, Deborah, Simmonds, Anne, Shaw, Dorothy, Lefebvre, Guylaine, Bouchard, Céline, Blake, Jennifer, Allen, Lisa, and Cassell, Krista

Published
2013
Full Text
View/download PDF

27. Relevance of omental pericellular adipose tissue collagen in the pathophysiology of human abdominal obesity and related cardiometabolic risk

Author

Michaud, Andréanne, Tordjman, Joan, Pelletier, Mélissa, Liu, Yuejun, Laforest, Sofia, Noël, Suzanne, Le Naour, Gilles, Bouchard, Céline, Clément, Karine, Tchernof, André, Michaud, Andréanne, Tordjman, Joan, Pelletier, Mélissa, Liu, Yuejun, Laforest, Sofia, Noël, Suzanne, Le Naour, Gilles, Bouchard, Céline, Clément, Karine, and Tchernof, André

Abstract

Background: Adipose tissue fibrosis is a relatively new notion and its relationship with visceral obesity and cardiometabolic alterations remains unclear particularly in moderate obesity. Objective: Our objective was to examine if total and pericellular collagen accumulation are relevant for the pathophysiology of visceral obesity and related cardiometabolic risk. Subjects and methods: Omental (OM) and subcutaneous (SC) fat surgical samples were obtained in 56 women (age: 47.2±5.8 years; BMI: 27.1±4.4kg/m2 ). Body composition and fat distribution were measured by dual-energy x-ray absorptiometry and computed tomography, respectively. Total and pericellular collagen were measured using picrosirius red staining and CD68+ cells, a marker of total macrophages, as well as CD163+ cells, a marker of M2-macrophages, were identified using immunohistochemistry. Results: We found that only pericellular collagen percentage, especially in OM fat, was associated with higher BMI, body fat mass and adipose tissue areas as well as lower radiologic attenuation of VAT and altered cardiometabolic risk variables. Strong correlations between peri-adipocyte collagen percentage and total or M2-macrophages percentage were observed in both depots. Total collagen percentage in either compartment was not related to adiposity, fat distribution or cardiometabolic risk. Conclusion: As opposed to whole-tissue based assessments of adipose tissue fibrosis, collagen deposition around the adipocyte, especially in the OM fat compartment is related to total and regional adiposity as well as altered cardiometabolic risk profile.

Published
2016

28. Vulvovaginite: Dépistage et prise en charge de la trichomonase, de la candidose vulvovaginale et de la vaginose bactérienne

Author

van Schalkwyk, Julie, primary, Yudin, Mark H., additional, Allen, Victoria, additional, Bouchard, Céline, additional, Boucher, Marc, additional, Boucoiran, Isabelle, additional, Caddy, Sheila, additional, Castillo, Eliana, additional, Kennedy, V. Logan, additional, Money, Deborah M., additional, Murphy, Kellie, additional, Ogilvie, Gina, additional, Paquet, Caroline, additional, and van Schalkwyk, Julie, additional

Published
2015
Full Text
View/download PDF

29. Lignes directrices quant à la prise en charge au Canada d’une femme enceinte ayant été exposée à la maladie à virus Ebola ou ayant été infectée par ce virus

Author

Money, Deborah, primary, Yudin, Mark H., additional, Allen, Victoria, additional, Bouchard, Céline, additional, Boucher, Marc, additional, Boucoiran, Isabelle, additional, Caddy, Sheila, additional, Castillo, Eliana, additional, Kennedy, V. Logan, additional, Money, Deborah, additional, Murphy, Kellie, additional, Ogilvie, Gina, additional, Paquet, Caroline, additional, and van Schalkwyk, Julie, additional

Published
2015
Full Text
View/download PDF

30. Lignes directrices pour ce qui est des soins à offrir aux femmes enceintes qui vivent avec le VIH et des interventions visant à atténuer la transmission périnatale : Résumé directif

Author

Money, Deborah, primary, Tulloch, Karen, additional, Boucoiran, Isabelle, additional, Caddy, Sheila, additional, Yudin, Mark H., additional, Allen, Victoria, additional, Bouchard, Céline, additional, Boucher, Marc, additional, Castillo, Eliana, additional, Gottlieb, Heather, additional, Kennedy, V. Logan, additional, Money, Deborah, additional, Murphy, Kellie, additional, Ogilvie, Gina, additional, Paquet, Caroline, additional, van Schalkwyk, Julie, additional, Alimenti, Ariane, additional, and Pick, Neora, additional

Published
2014
Full Text
View/download PDF

31. Prostaglandin (PG) F2 Alpha Synthesis in Human Subcutaneous and Omental Adipose Tissue: Modulation by Inflammatory Cytokines and Role of the Human Aldose Reductase AKR1B1

Author

Michaud, Andréanne, primary, Lacroix-Pépin, Nicolas, additional, Pelletier, Mélissa, additional, Veilleux, Alain, additional, Noël, Suzanne, additional, Bouchard, Céline, additional, Marceau, Picard, additional, Fortier, Michel A., additional, and Tchernof, André, additional

Published
2014
Full Text
View/download PDF

32. Best Practices to Minimize Risk of Infection With Intrauterine Device Insertion

Author

Caddy, Sheila, primary, Yudin, Mark H., additional, Hakim, Julie, additional, Money, Deborah M., additional, Allen, Victoria M., additional, Bouchard, Céline, additional, Boucher, Marc, additional, Caddy, Sheila, additional, Castillo, Eliana, additional, Murphy, Kellie E., additional, Ogilvie, Gina, additional, Paquet, Caroline, additional, and Norman, Wendy V., additional

Published
2014
Full Text
View/download PDF

33. Pratiques optimales en vue de minimiser le risque d’infection au moment de l’insertion d’un dispositif intra-utérin

Author

Caddy, Sheila, primary, Yudin, Mark H., additional, Hakim, Julie, additional, Money, Deborah M., additional, Allen, Victoria M., additional, Bouchard, Céline, additional, Boucher, Marc, additional, Caddy, Sheila, additional, Castillo, Eliana, additional, Murphy, Kellie E., additional, Ogilvie, Gina, additional, Paquet, Caroline, additional, and Norman, Wendy V., additional

Published
2014
Full Text
View/download PDF

34. Chirurgie esthétique génitale chez la femme

Author

Shaw, Dorothy, primary, Lefebvre, Guylaine, additional, Bouchard, Céline, additional, Shapiro, Jodi, additional, Blake, Jennifer, additional, Allen, Lisa, additional, Cassell, Krista, additional, Leyland, Nicholas, additional, Wolfman, Wendy, additional, Allaire, Catherine, additional, Awadalla, Alaa, additional, Best, Carolyn, additional, Dunn, Sheila, additional, Heywood, Mark, additional, Lemyre, Madeleine, additional, Marcoux, Violaine, additional, Menard, Chantal, additional, Potestio, Frank, additional, Rittenberg, David, additional, Singh, Sukhbir, additional, Akhtar, Saima, additional, Camire, Bruno, additional, Christilaw, Jan, additional, Corey, Julie, additional, Nelson, Erin, additional, Pierce, Marianne, additional, Robertson, Deborah, additional, and Simmonds, Anne, additional

Published
2013
Full Text
View/download PDF

35. Prévention de l’infection néonatale à streptocoques du groupe B d’apparition précoce

Author

Money, Deborah, primary, Allen, Victoria M., additional, Yudin, Mark H., additional, Bouchard, Céline, additional, Boucher, Marc, additional, Caddy, Sheila, additional, Castillo, Eliana, additional, Money, Deborah, additional, Murphy, Kellie E., additional, Ogilvie, Gina, additional, Paquet, Caroline, additional, Senikas, Vyta, additional, and van Schalkwyk, Julie, additional

Published
2013
Full Text
View/download PDF

37. Toxoplasmose pendant la grossesse: Prévention, dépistage et traitement

Author

Paquet, Caroline, primary, Yudin, Mark H., additional, Allen, Victoria M., additional, Bouchard, Céline, additional, Boucher, Marc, additional, Caddy, Sheila, additional, Castillo, Eliana, additional, Money, Deborah M., additional, Murphy, Kellie E., additional, Ogilvie, Gina, additional, Paquet, Caroline, additional, van Schalkwyk, Julie, additional, and Senikas, Vyta, additional

Published
2013
Full Text
View/download PDF

38. Toxoplasmosis in Pregnancy: Prevention, Screening, and Treatment

Author

Paquet, Caroline, primary, Yudin, Mark H., additional, Allen, Victoria M., additional, Bouchard, Céline, additional, Boucher, Marc, additional, Caddy, Sheila, additional, Castillo, Eliana, additional, Money, Deborah M., additional, Murphy, Kellie E., additional, Ogilvie, Gina, additional, Paquet, Caroline, additional, van Schalkwyk, Julie, additional, and Senikas, Vyta, additional

Published
2013
Full Text
View/download PDF

40. Prise en charge de la bactériurie à streptocoques du groupe B pendant la grossesse

Author

Allen, Victoria M., primary, Yudin, Mark H., additional, Allen, Victoria M., additional, Bouchard, Céline, additional, Boucher, Marc, additional, Caddy, Sheila, additional, Castillo, Eliana, additional, Money, Deborah M., additional, Murphy, Kellie E., additional, Ogilvie, Gina, additional, Paquet, Caroline, additional, van Schalkwyk, Julie, additional, and Senikas, Vyta, additional

Published
2012
Full Text
View/download PDF

41. Management of Group B Streptococcal Bacteriuria in Pregnancy

Author

Allen, Victoria M., primary, Yudin, Mark H., additional, Allen, Victoria M., additional, Bouchard, Céline, additional, Boucher, Marc, additional, Caddy, Sheila, additional, Castillo, Eliana, additional, Money, Deborah M., additional, Murphy, Kellie E., additional, Ogilvie, Gina, additional, Paquet, Caroline, additional, Schalkwyk, Julie van, additional, and Senikas, Vyta, additional

Published
2012
Full Text
View/download PDF

42. Antibiotic Prophylaxis in Gynaecologic Procedures

Author

Van Eyk, Nancy, primary, van Schalkwyk, Julie, additional, Yudin, Mark H., additional, Allen, Victoria M., additional, Bouchard, Céline, additional, Boucher, Marc, additional, Caddy, Sheila, additional, Castillo, Eliana, additional, Money, Deborah M., additional, Murphy, Kellie E., additional, Ogilvie, Gina, additional, Paquet, Caroline, additional, and Senikas, Vyta, additional

Published
2012
Full Text
View/download PDF

43. Antibioprophylaxie dans le cadre d’interventions gynécologiques

Author

Van Eyk, Nancy, primary, van Schalkwyk, Julie, additional, Yudin, Mark H., additional, Allen, Victoria M., additional, Bouchard, Céline, additional, Boucher, Marc, additional, Caddy, Sheila, additional, Castillo, Eliana, additional, Money, Deborah M., additional, Murphy, Kellie E., additional, Ogilvie, Gina, additional, Paquet, Caroline, additional, Schalkwyk, Julie van, additional, and Senikas, Vyta, additional

Published
2012
Full Text
View/download PDF

45. RETIRED: Lignes directrices pour ce qui est des soins à offrir aux femmes enceintes qui vivent avec le VIH et des interventions visant à atténuer la transmission périnatale : Résumé directif

Author

Yudin, Mark H., Allen, Victoria, Bouchard, Céline, Boucher, Marc, Boucoiran, Isabelle, Caddy, Sheila, Castillo, Eliana, Gottlieb, Heather, Kennedy, V. Logan, Money, Deborah, Murphy, Kellie, Ogilvie, Gina, Paquet, Caroline, van Schalkwyk, Julie, Alimenti, Ariane, Pick, Neora, and Tulloch, Karen

Published
2014
Full Text
View/download PDF

48. L'estampe originale au Québec, 1980-1990

Author

Malenfant, Nicole, Dumont, Jean, Paul, Francine, Hould, Claudette, Letocha, Louise, Delagrave, Marie, Doyon, Pierre-Simon, Lupien, Lucette, Doré, Madeleine, Ouellet, Monique, Bouchard, Céline, Gilbert, Jean-Pierre, Malenfant, Nicole, Dumont, Jean, Paul, Francine, Hould, Claudette, Letocha, Louise, Delagrave, Marie, Doyon, Pierre-Simon, Lupien, Lucette, Doré, Madeleine, Ouellet, Monique, Bouchard, Céline, and Gilbert, Jean-Pierre

Published
1991

50. RETIRED: Lignes directrices pour ce qui est des soins à offrir aux femmes enceintes qui vivent avec le VIH et des interventions visant à atténuer la transmission périnatale : Résumé directif

Author

Money, Deborah, Tulloch, Karen, Boucoiran, Isabelle, Caddy, Sheila, Yudin, Mark H., Allen, Victoria, Bouchard, Céline, Boucher, Marc, Boucoiran, Isabelle, Caddy, Sheila, Castillo, Eliana, Gottlieb, Heather, Kennedy, V. Logan, Money, Deborah, Murphy, Kellie, Ogilvie, Gina, Paquet, Caroline, van Schalkwyk, Julie, Alimenti, Ariane, and Pick, Neora

Abstract

This document has been archived because it contains outdated information. It should not be consulted for clinical use, but for historical research only. Please visit the journal website for the most recent guidelines.

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results